
CLBT
USDCellebrite DI Ltd. Ordinary Shares
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$20.040
고가
$20.530
저가
$20.010
거래량
0.13M
기업 기본 정보
시가총액
4.8B
산업
Software - Infrastructure
국가
Israel
거래 통계
평균 거래량
1.61M
거래소
NMS
통화
USD
52주 범위
AI 분석 리포트
마지막 업데이트: 2025년 5월 4일CLBT (Cellebrite DI Ltd. Ordinary Shares): What's Happening and What to Watch
Stock Symbol: CLBT Generate Date: 2025-05-04 08:27:10
Let's break down what's been going on with Cellebrite stock lately, looking at the news, how the price has moved, and what some predictions are saying.
The Latest Buzz
The news flow around Cellebrite seems pretty positive right now. A big point is that Needham, an investment firm, has stuck with their "Buy" rating on the stock, and they're keeping a price target of $28. They've actually reiterated this target twice recently, once in late March and again in early April. That kind of repeated confidence from analysts can definitely catch investors' eyes.
Beyond the analyst view, the company also announced its first-ever "Digital Justice Awards," which sounds like a good bit of positive PR, highlighting their role in the digital investigation space. Filing their annual report is standard business, not really news unless something surprising was in it (which wasn't indicated here). So, overall, the news coming out leans favorable, especially with that analyst target hanging out there.
Checking the Price Chart
Looking back over the last few months, CLBT has had a bit of a rollercoaster ride. It started February up around the $23-$25 range, even touching $26 briefly. Then, things took a noticeable dip through the middle and end of February, dropping into the $19-$20 area. March saw it bounce around, even dipping below $17 at one point before starting to climb back.
More recently, in April and early May, the stock has been trading mostly between $18 and $20. It closed on May 2nd right around $20.14. So, after that earlier slide, it looks like the price has been trying to find its footing and has edged up slightly into the $20 territory.
Now, the AI prediction tool is forecasting upward movement for the next few days – predicting gains of 1.45% today, 3.08% tomorrow, and 4.20% the day after. If that plays out, it would continue this recent gentle upward trend, maybe even accelerating it a bit.
Putting It All Together: What Might This Mean?
Based on the positive analyst view, the recent upward nudge in price, and the AI's bullish short-term prediction, the situation for CLBT in the very near term seems to lean positive. The news sentiment is good, and the AI is calling for more gains.
So, what could an investor consider?
- Potential Entry Idea: If you're thinking about getting in, the current price area, right around $20, looks interesting. The AI prediction suggests this level could be a launching point for a short-term move up. The AI's data even points to potential entry spots around $20.27 or $20.40, which are right there. It also notes the price is near a support level, which could offer a bit of a cushion.
- Managing Risk: No investment is a sure thing, right? If you decide to jump in, having a plan for when to get out is smart. The AI suggests a stop-loss level around $18.12. This is below recent lows and could be a point to consider cutting losses if the price turns south unexpectedly.
- Potential Upside: For taking profits, the AI gives a short-term target of $20.53. That's not a huge jump from the current price, but it aligns with a quick trading idea. Looking further out, the AI projects a potential target of $24.58, and the Needham analyst is way up at $28. These higher numbers show there's perceived room to grow if the positive momentum builds.
A Little Company Context
Remember, Cellebrite is a company focused on digital investigation tools. They help law enforcement and businesses handle digital evidence in various cases, from cybercrime to corporate security. This means their business is tied to the needs of these sectors. While the news and predictions look good right now, it's always worth keeping the company's fundamentals in mind. The data provided does flag a few things like a high P/E ratio (meaning the stock is expensive compared to its earnings), lower-than-expected growth, and high debt. These are factors that could weigh on the stock longer term, even if the short-term picture looks brighter due to sentiment and predictions.
This analysis is based purely on the data provided and is intended for informational purposes only. It's not financial advice. Stock markets are unpredictable, and prices can go down as well as up. Always do your own thorough research or talk to a qualified financial advisor before making any investment decisions.
관련 뉴스
Needham Reiterates Buy on Cellebrite DI, Maintains $28 Price Target
Needham analyst Mike Cikos reiterates Cellebrite DI with a Buy and maintains $28 price target.
10 Winners Awarded "Justies" at Cellebrite's First-Ever Digital Justice Awards
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors, awarded ten winners
Needham Reiterates Buy on Cellebrite DI, Maintains $28 Price Target
Needham analyst Mike Cikos reiterates Cellebrite DI with a Buy and maintains $28 price target.
Cellebrite Files its 2024 Annual Report on Form 20-F
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the
AI 예측Beta
AI 추천
업데이트 시간: 2025년 5월 4일 오전 06:24
74.1% 신뢰도
리스크 & 트레이딩
진입점
$20.27
익절
$20.53
손절
$18.12
핵심 요소
관련 주식
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기